Emtricitabine (FTC, Emtriva)
Overview
- A Clinical Overview of Emtricitabine (FTC, Emtriva) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Emtricitabine (FTC, Emtriva) (PDF) (December 2006)
From Gilead Sciences, Inc. - Labeling Changes for Emtriva (September 28, 2005)
Specific modifications since the label was last updated are highlighted.
From U.S. Food and Drug Administration - Approval of Emtriva for Treating HIV (July 2, 2003)
From U.S. Food and Drug Administration - FTC Has Been Approved: What Now? (July 2003)
An analysis of what we know so far -- and what we have yet to learn.
In TAGline, from Treatment Action Group - Separated at Birth: 3TC and FTC (July 2003)
A quick comparison of molecular structures.
In TAGline, from Treatment Action Group
Research & News
- Literature Citations for Emtricitabine (Regularly Updated)
From U.S. National Institutes of Health - Prospective Randomized Trial of Emtricitabine Versus Lamivudine Short-Term Monotherapy in Human Immunodeficiency Virus-Infected Patients
In Journal of Infectious Diseases - Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - Emtriva: New Pediatric Formulation and Labeling Changes (September 28, 2005)
From U.S. Food and Drug Administration - Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration - Food and Drug Administration to Expedite Decision on Emtricitabine/Tenofovir Pill (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Emtricitabine: A New Nucleoside Analogue for Once-Daily Antiretroviral Therapy (January 2004)
In Expert Opinion on Investigational Drugs - No PK Interaction Seen Between FTC and AZT or Tenofovir (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - FTC Compares Well to 3TC in Triple-NRTI Regimens (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - FTC Similar in Most Ways to 3TC (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Comparison of Once-Daily FTC Vs. Twice-Daily Abacavir in a Regimen for Drug-Naive Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Forty-Eight Week Data From FTC-d4T Comparison in Treatment-Naive Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - FTC Potent Within a HAART Regimen in Treatment-Naive HIV-Infected Patients With High Viral Loads (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Incidence of Symptomatic Hyperlactatemia With FTC (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Anti-HIV Drug Updates -- Three Drugs on the Near Horizon (January 2003)
Research from Barcelona on T-20, atazanavir and emtricitabine.
To read PDF, click here
In Project Inform Perspective, from Project Inform - Coviracil (FTC) Enters the Home Stretch (December 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis - Research From the 42nd ICAAC: A Nucleoside (FTC) and a Nucleotide (Tenofovir) Outdo d4T (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Drug Company Gets Good News on FTC, Bad News on DAPD (September 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis - FTC Superiority Over d4T in Phase III Trial (September/October 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - Long-Term Efficacy and Safety of Emtricitabine (FTC) in HIV-Positive Adults Switching from a Lamivudine (3TC)-Containing HAART Regimen (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
Clinical Management
Clinical Management
  |